Trial Profile
A Double Blind Study to Investigate the Clinical Efficacy and Safety of Ragweed MATAMPL (Allergy Therapeutics), Pollinex-R (Allergy Therapeutics) and Placebo in Patients With Seasonal Allergic Rhinitis With Ragweed Allergy, in an Environmental Exposure Chamber (EEC) Model, With Follow-Up During a Natural Ragweed Pollen Season
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2009
Price :
$35
*
At a glance
- Drugs Ragweed allergy immunotherapy (Primary)
- Indications Seasonal allergic rhinitis
- Focus Registrational; Therapeutic Use
- 08 Oct 2005 New trial record.